Kannaway will be expanding its capabilities into the European market through its new agreement with its long-time partner, CHT.
Kannaway’s new agreement will add warehousing and daily operations to the services that CHT already provides to Kannaway in Europe.
The company has stated that this will provide cost-savings and gross margins improvements in one of its largest international markets.
Medical Marijuana, Inc. CEO Blake Schroeder, commented: “As the first US company to enter Europe with our hemp-based products, we have built long-standing relationships with the region’s most knowledgeable companies and this agreement is a perfect example of that.
Read more: Lyphe Group to create European cannabis powerhouse with Materia acquisition
“It is a win-win for both companies. We will continue to leverage our superior product formulations and brand equity as the original trusted source for quality products, while being supported by a reputable company with a proven track record of success.”
CEO of Complete Hemp Technologies, Rafal Modlinski, commented: “We are happy to continue to work with Medical Marijuana, Inc. and its family of companies.
“Their dedication to creating quality products and distributing them on a global basis fully aligns with our vision here at CHT. Through this agreement, we will be able to expand both our reach and the reach of Medical Marijuana, Inc. and Kannaway products.”
Kannaway has worked with CHT for years to facilitate expansion throughout Europe, leveraging strong relationships with regulators and industry-leading cannabis-based product capabilities.
CHT will also now provide distribution services eliminating the need to transport product after manufacture as well as fund additional warehouse space and associated labour costs.
[activecampaign form=31]
